Hv SSE STAR Bio Medicine ETF (588700)
Market Open
12 Aug, 06:57
SSE SSE Primary ¥
1. 04
-0
-0.4776%
¥
- Market Cap
- Div Yield
96.62M Volume
¥ 1.05
Previous Close Want to track 588700 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
588700 trading today lower at ¥1.04, a decrease of -0.4776% from yesterday's close, completing a monthly increase of 8.2035% or ¥0.08. Over the past 12 months, 588700 stock lost -0.6673%.
588700 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
588700 Chart
Hv SSE STAR Bio Medicine ETF (588700) FAQ
What is the stock price today?
The current price is ¥1.04.
On which exchange is it traded?
Hv SSE STAR Bio Medicine ETF is listed on SSE.
What is its stock symbol?
The ticker symbol is 588700.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Hv SSE STAR Bio Medicine ETF ever had a stock split?
No, there has never been a stock split.
Hv SSE STAR Bio Medicine ETF Profile
| SSE Exchange | China Country |
The Hv SSE STAR Bio Medicine ETF is an exchange-traded fund specifically focused on capturing the growth and innovation within China’s burgeoning biotechnology sector. This ETF primarily tracks companies listed on the Shanghai Stock Exchange’s STAR Market—a platform designed to support the development of science and technology-driven enterprises. By investing in the bio-medicine industry, the ETF highlights its emphasis on sectors such as pharmaceuticals, biotechnology research and development, medical diagnostics, and healthcare technology.
The primary function of the Hv SSE STAR Bio Medicine ETF is to offer investors targeted exposure to the dynamic and rapidly evolving field of biotechnology in China, a region experiencing significant investment and innovation in this sector. By reflecting the performance of leading biotech firms, it provides a vehicle for investors to engage with the advancements in medical research, drug development, and innovative healthcare solutions. Within the financial market, this ETF plays a crucial role in diversifying portfolios that seek to benefit from the growing demand for biotechnological advancements and healthcare solutions, driven by demographic changes and increased healthcare awareness.
Contact Information
Address: -
Phone: -
